Clinical Trial Update: Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults [Phase 1]

View source ↗

Summary

Phase 1 trial update showing safety and immunogenicity of GlaxoSmithKline's Herpes Zoster Vaccine 1437173A in healthy ethnic Japanese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Herpes Zoster Vaccine 1437173A (Herpes zoster vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Zoster | Phase 1 | Status: COMPLETED